CoChat

RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation

Open access

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index; 17 of the 51 sources its claims cite were checked for support.

Abstract

Ferroportin (FPN), the body’s sole iron exporter, is essential for maintaining systemic iron homeostasis. In response to either increased iron or inflammation, hepatocyte-secreted hepcidin binds to FPN, inducing its internalization and subsequent degradation. However, the E3 ubiquitin ligase that underlies FPN degradation has not been identified. Here, we report the identification and characterization of a novel mechanism involving the RNF217-mediated degradation of FPN. A combination of 2 different E3 screens revealed that the Rnf217 gene is a target of Tet1, mediating the ubiquitination and subsequent degradation of FPN. Interestingly, loss of Tet1 expression causes an accumulation of FPN and an impaired response to iron overload, manifested by increased iron accumulation in the liver together with decreased iron in the spleen and duodenum. Moreover, we found that the degradation and ubiquitination of FPN could be attenuated by mutating RNF217. Finally, using 2 conditional knockout mouse lines, we found that knocking out Rnf217 in macrophages increases splenic iron export by stabilizing FPN, whereas knocking out Rnf217 in intestinal cells appears to increase iron absorption. These findings suggest that the Tet1-RNF217-FPN axis regulates iron homeostasis, revealing new therapeutic targets for FPN-related diseases.

Overview

CoChat Summary

TL;DR

This study identifies RNF217 as an E3 ubiquitin ligase that promotes ferroportin (FPN) degradation and is transcriptionally controlled by the iron-responsive demethylase TET1. The TET1–RNF217–FPN axis helps maintain iron homeostasis mainly under iron-loaded conditions, with cell-type-specific effects in macrophages and intestinal enterocytes.

Key findings

  • Iron overload increased Tet1 expression and 5-hmC levels in mouse liver, spleen, enterocytes, and BMDMs; global Tet1 knockout mice on a high-iron diet showed higher serum iron and transferrin saturation, nonheme iron accumulation in liver, lungs, and pancreas, and lower splenic iron, along with increased FPN protein in duodenum, spleen, and liver.
  • Rnf217 was downregulated in Tet1−/− BMDMs and enterocytes; its promoter was more methylated in Tet1−/− BMDMs (14.5% vs 2.5%), and 5-hmC was lower at three Rnf217 promoter regions.
  • RNF217 interacted with FPN, increased FPN polyubiquitination, and promoted FPN degradation without significantly affecting TFR1 or DMT1; RBR-domain mutants (C409A or C236A/C239A) reduced FPN degradation, and both proteasome and lysosome inhibitors reduced RNF217-mediated FPN loss.
  • Macrophage-specific Rnf217 knockout increased splenic FPN and reduced splenic iron, with significant splenic iron reduction at 5 months; hepcidin injection produced higher splenic FPN and serum iron than in controls, and LPS-induced hypoferremia was less severe. Enterocyte-specific Rnf217 knockout at 6 months reduced duodenal nonheme iron and increased hepatic iron, with increased duodenal FPN; under high-iron feeding, duodenal iron was lower and hepatic iron higher than controls.

Methods

  • Mouse models included global Tet1 knockout, Rnf217flox/flox controls, and conditional Rnf217 deletion using Lysm-Cre (macrophages) or Villin-Cre (intestinal enterocytes); mice were fed standard, high-iron, or low-iron diets and treated with iron dextran, hepcidin, or LPS.
  • Cell and biochemical work used BMDMs, isolated intestinal enterocytes, HEK293T, and HeLa cells; assays included RNA-seq, whole-genome bisulfite sequencing, RT-PCR, western blot, co-IP, ubiquitination assays, immunofluorescence, Perls’ Prussian blue/DAB staining, calcein-AM iron measurement, and yeast two-hybrid screening with FPN as bait against a library of over 400 E3 ubiquitin ligases or substrate-binding subunits.
  • Statistics used mean ± SEM, at least triplicate experiments, Student t test or one-way ANOVA with Tukey’s post hoc test, with P < .05 considered significant.

Limitations

  • The paper states that LysM-Cre expression can vary across tissues and macrophage populations are heterogeneous, so other Cre lines such as F4/80-Cre or CX3CR1-ER-Cre may be needed; it also notes possible compensatory regulation of FPN, lack of phenotype without provocation or aging, and no detectable FPN protein differences without cycloheximide in ex vivo studies.
  • The paper states that whether RNF217 ubiquitinates FPN at the plasma membrane, ER, or endosome remains unresolved, that residual hepcidin in culture could not be excluded, and that duodenal nonheme iron was measured in whole duodenum and may include non-epithelial cells.
  • Evident from the text: the findings rely on mouse models and cultured cell lines, with no human cohort or clinical validation reported; several mechanistic conclusions come from overexpression systems, and the conditional knockout macrophages still eventually degraded FPN despite near-complete RNF217 loss.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1182/blood.2020008986

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

7 Valid · 1 Not valid · 18 Not checked · 118 Own results and interpretations

79 more claims

Create a free account to see all 144 claims and to verify the 34 references still open.

See all claims — free account
  • Probably not a substantial claim. 16
  • It may state two separate claims as one. 48
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 74 references

Cited by

See all 144

Metadata

Authors
Jiang, L., Wang, J., Wang, K., Wang, H., Wu, Q., Yang, C., Yu, Y., Ni, P., Zhong, Y., Song, Z., Xie, E., Hu, R., Min, J., & Wang, F.
Affiliations
  • Zhengzhou University (CN)
  • First Affiliated Hospital Zhejiang University (CN)
  • Chinese Academy of Sciences (CN)
Corresponding author
  • Min, Junxia
  • Wang, Fudi
Venue
Blood
Published
2021-04-25
Volume
138
Issue
8
Pages
689-705
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W3159315107
Cited by
138
References
74
Citations by year
2026: 18 · 2025: 29 · 2024: 40 · 2023: 26 · 2022: 17 · 2021: 8
FWCI
14.87
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords
ferroportin, iron homeostasis, E3 ubiquitin ligase, protein degradation, TET1, ubiquitination, iron overload, hepcidin, iron export, macrophages, intestinal iron absorption, liver iron deposition
MeSH terms
Ferroportin, Animals, Carrier Proteins, DNA-Binding Proteins, Iron, Organ Specificity, Proto-Oncogene Proteins, Mice, Knockout, Iron Overload, Cation Transport Proteins, Ubiquitin-Protein Ligases, Mice, Ubiquitination, Proteolysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation. https://app.cochat.ai/papers/10.1182/blood.2020008986
The paper
Jiang, L., Wang, J., Wang, K., Wang, H., Wu, Q., Yang, C., Yu, Y., Ni, P., Zhong, Y., Song, Z., Xie, E., Hu, R., Min, J., & Wang, F. (2021). RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation. Blood. https://doi.org/10.1182/blood.2020008986

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.